Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of rivastigmine capsules in patients with probable vascular dementia.

Trial Profile

Efficacy and safety of rivastigmine capsules in patients with probable vascular dementia.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2011

At a glance

  • Drugs Rivastigmine (Primary)
  • Indications Vascular dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2011 Actual initiation date changed from Jul 2001 to Aug 2001 as reported by ClinicalTrials.gov.
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top